Publicaciones
-
Ibañez-Toda L, Valls C, Cabré-Gili S and De Zegher F.
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism:: The key role of early, low-dose flutamide
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 89(9): 4716-4720. Nº de citas: 49
-
López-Bermejo A, Casano-Sancho P, Fernández-Real JM, Kihara S, Funahashi T, Rodríguez-Hierro F, Ricart W and Ibañez-Toda L.
Both intrauterine growth restriction and postnatal growth influence childhood serum concentrations of adiponectin
CLINICAL ENDOCRINOLOGY . 61(3): 339-346. Nº de citas: 29
-
Ibañez-Toda L and De Zegher F.
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome:: switch from third- to fourth-generation OC reduces body adiposity
HUMAN REPRODUCTION . 19(8): 1725-1727. Nº de citas: 39
-
Ong KK, Potau N, Petry CJ, Jones R, Ness AR, Honour JW, de Zegher F, Ibañez-Toda L and Dunger DB.
Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 89(6): 2647-2651. Nº de citas: 188
-
Curcoy-Barcenilla AI, Trenchs-Sainz de la Maza V, Ibañez-Toda L and R. Hierro F.
[Influence of birthweight on the onset and progression of puberty and final height in precocious pubarche].
ANALES DE PEDIATRIA . 60(5): 436-9. Nº de citas: 3
-
Ibañez-Toda L and de Zegher F.
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism:: Opposite effects on adipocytokines and body adiposity
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 89(4): 1592-1597. Nº de citas: 139
-
Chang, J, Azziz, R, Legro, R, Dewailly, D, Franks, S, Tarlatzis, BC, Fauser, B, Balen, A, Bouchard, P, Dahlgren, E, Devoto, L, Diamanti, E, Dunaif, A, Filicori, M, Homburg, R, Ibañez-Toda L, Laven, J, Magoffin, D, Nestler, J, Norman, RJ, Pasquali, R, Pugeat, M, Strauss, J, Tan, S, Taylor, A, Wild, R, Wild, S, Ehrmann, D, Lobo, R and Rotterdam ESHRE ASRM Sponsored.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
FERTILITY AND STERILITY . 81(1): 19-25. Nº de citas: 4746
-
Fauser, BCJM, Chang, J, Azziz, R, Legro, R, Dewailly, D, Franks, S, Tarlatzis, BC, Fauser, B, Balen, A, Bouchard, P, Dahlgren, E, Devoto, L, Diamanti, E, Dunaif, A, Filicori, M, Homburg, R, Ibañez-Toda L, Laven, J, Magoffin, D, Nestler, J, Norman, RJ, Pasquali, R, Pugeat, M, Strauss, J, Tan, S, Taylor, A, Wild, R, Wild, S, Ehrmann, D, Lobo, R and Rotterdam ESHRE-ASRM-sponsored.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
HUMAN REPRODUCTION . 19(1): 41-47. Nº de citas: 4491
-
de Zegher F and Ibañez-Toda L.
Novel insights into the endocrine-metabolic and reproductive consequences of prenatal growth restraint in girls. Girls-born-small become women-born-small.
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie . 66(5-6): 353-82. Nº de citas: 3
-
Ibañez-Toda L, Ferrer A, Ong K, Amin R, Dunger D and de Zegher F.
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome
JOURNAL OF PEDIATRICS . 144(1): 23-29. Nº de citas: 109